Edge Rock Capital LLC Johnson & Johnson Transaction History

Edge Rock Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $272,095 - $304,816	1,747 New	1,747 $272,000
Q1 2023 Apr 13, 2023	BUY	$151.05 - $180.26 $22,808 - $27,219	151 Added 13.12%	1,302 $202,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $4,485 - $5,034	-28 Reduced 2.37%	1,151 $203,000
Q3 2022 Oct 14, 2022	SELL	$161.33 - $179.52 $47,431 - $52,778	-294 Reduced 19.96%	1,179 $193,000
Q2 2022 Aug 03, 2022	BUY	$168.19 - $186.01 $247,743 - $273,992	1,473 New	1,473 $261,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Edge Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Rock Capital LLC with notifications on news.